1. Evaluating MicroRNAs as diagnostic tools for lymph node metastasis in breast cancer: Findings from a systematic review and meta-analysis.
- Author
-
Martínez CG, Therapontos S, Lorente JA, Lucena MA, Ortega FG, and Serrano MJ
- Subjects
- Humans, Female, Prognosis, Breast Neoplasms pathology, Breast Neoplasms genetics, Breast Neoplasms diagnosis, MicroRNAs genetics, Lymphatic Metastasis diagnosis, Lymphatic Metastasis genetics, Lymphatic Metastasis pathology, Biomarkers, Tumor genetics
- Abstract
Lymph node metastasis (LNM) significantly affects the prognosis and clinical management of breast cancer (BC) patients. This systematic review and meta-analysis aim to identify microRNAs (miRNAs) associated with LNM in BC and evaluate their potential diagnostic and prognostic value. Following PRISMA guidelines, a comprehensive literature search was conducted in PubMed, Web of Science, and SCOPUS databases, to assess the role of miRNAs in LNM BC. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool was used to evaluate the quality of included studies. A total of 84 miRNAs were identified as differentially expressed in BC patients with LNM. Of these, a meta-analysis was performed in two microRNAs that were present in at least 3 different articles with a coherent expression direction: miR-155 and miR-34a. The meta-analysis returned a pooled a Log2 fold change of 1.50 for miR-155 (upregulated) and -0.53 for miR-34a (downregulated) with no evidence of publication bias, and a low risk of bias and applicability concerns. To conclude, this study names miR-155 and miR-34a as potential diagnostic biomarkers for LNM in BC, although further experimental validation is necessary to confirm these findings and develop non-invasive diagnostic tools for clinical use., Competing Interests: Declaration of Competing Interest Authors declare no conflict of interests and did not receive any fund for this manuscript., (Copyright © 2025 Elsevier B.V. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF